Prostate Cancer: Why are we ignoring prostate cancer? The silent epidemic affecting millions of men
Tired of too many ads? go ad free now
The silent intruder
Prostate cancer starts in the prostate gland, which is one of the accessory gland of the male sex situated just beneath the bladder and ahead of the rectum. It has an important role along with seminal vesicle in male fertility, secreting seminal fluid that nourishes sperm and carries sperm.
What is so risky about prostate cancer is that it can go on silently, particularly during its initial stages. Most men do not have symptoms until the cancer has progressed.
Indeed, some are diagnosed by chance while undergoing standard health examinations or testing for other ailments.
Identifying the symptoms
Despite early prostate cancer not having symptoms, men should note warning signs that include:
● Frequent urination, particularly at night
● Straining or inability to start or stop urination
● Weakened or interrupted stream of urine
● Painful or burning sensation on urination
● Blood in urine or semen
● Pelvic, back, or hip pain (indicative of more advanced disease)
It is noteworthy that the symptoms can also be due to benign prostatic hyperplasia (BPH) or urinary tract infection.
But neglecting them or attributing them to it's "just age catching up" can lead to delayed diagnosis and treatment.
Who's at risk?
Though prostate cancer is diagnosed most frequently in men above the age of 50 years, some conditions raise the risk:
● Age: Risk becomes a lot higher after 50 years. Median age at diagnosis moved to 67 from 70 years a decade ago.
● Hereditary: >3 such cases in the same family or > 2 such cases diagnosed < 55 years have a high risk.
Tired of too many ads? go ad free now
● Family history: 2 first-degree relatives or 1 first degree relative and > 2 second degree relative are at high risk.
● Genetic - Germline mutations such as BRCA2, HOXB13, BRCA1, CHEK2, ATM, MMR genes etc
● Race: African and Afro-Caribbean men are at higher risk, although data in Indian men is increasing
● Lifestyle: Metabolic syndrome, Alcohol, High fried food diet, red and processed meat and obesity have been linked to increased risk
Diagnosis and screening
Globally, the Prostate-Specific Antigen (PSA) blood test and Digital Rectal Examination (DRE) are the primary tools for screening.
Though these are not foolproof diagnostic methods, they help identify men who may require further evaluation.
Once there is suspicion, imaging examinations such as mpMRI - multiparametric MRI, and a prostate biopsy (in which a small amount of tissue is checked for cancer cells), are employed to establish the diagnosis.
No national screening program exists in India, and routine screening is not practiced for all due to overdiagnosis concerns.
Yet, for men over 50 — or 45 if there is a family history — yearly screening can be lifesaving.
Modern treatment strategies
Treatment varies by stage and grade of cancer, along with the patient's age, overall health, and personal preferences. The primary choices are:
● Active Surveillance: For low-risk cancer in older men, where active surveillance is preferred to treatment right away
● Surgery: Radical prostatectomy (removal of the prostate) is commonly performed when cancer is localized
● Radiation Therapy: External beam and internal radiation (brachytherapy) are utilized
● Hormone Therapy: Reduces testosterone levels, which prostate cancer requires for growth
● Chemotherapy and Immunotherapy: Applied in case of advanced or resistant diseases
New methods such as robotic surgery and targeted therapy are becoming increasingly popular in top Indian hospitals on par with western hospitals, providing greater precision and quick recovery.
Life after diagnosis
Prostate cancer diagnosis can be emotionally devastating. The good news is that survival rates are excellent, particularly if it is diagnosed early. In a well functioning man, early localized prostate cancer has a 5-year survival rate of more than 98%.
After treatment, some men will have problems such as incontinence or erectile dysfunction. Rehabilitation, physiotherapy, counseling, and drugs can control these problems.
Support groups, increasingly available in India's cities, also offer emotional support and solidarity.
Breaking the silence
In Indian society, where discussions about men's health — particularly below-the-belt matters — remain whispered, awareness is the priority. Men need to be motivated to open up, get regular checks, and make their wellbeing a priority equally as that of their families.
Your life is important. Get tested. Speak with your physician. Live stronger.
Dr. Chandan MN - MCh Urology - Consultant Apollo Hospital Sheshadripuram, Bengaluru
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 days ago
- The Hindu
Move on HPV vaccine rollout to adolescent girls raises other vaccination priorities for Kerala: epidemiologists
Kerala's decision to introduce HPV vaccination targeting adolescent girls, to protect them from cervical cancer is generally hailed as a positive public health measure. However, health experts have pointed out that the State has other pressing public health concerns, where also vaccination strategies must be prioritised. Going by the current data from the population-based and hospital-based cancer registries in Kerala, the incidence of cervical cancer has been on a steady decline in the State over the past several years and it no longer figures among the top five cancers affecting women in Kerala, according to epidemiologists. This is consistent with improvements in women's health and hygiene, better sexual practices, education and healthcare access in Kerala. Even though the World Health Organization (WHO) has recommended HPV vaccination for adolescent girls, in Kerala cervical cancer incidence is only eight per lakh population, even when at the national level, cervical cancer remained the second highest of all cancers reported amongst women as in 2022. 'Only if there is an uptick' The committee headed by Dr. B. Ekbal, which submitted the State's Vaccine Policy recommendations in November 2022, had noted that HPV vaccination should be considered in Kerala only if there is an increasing trend in the incidence of cervical cancer from the current baseline. It said that given the fact that the cost of vaccinating 13 lakh adolescent girls would be over ₹200 crore, HPV vaccination was not indicated, nor was it cost effective. Dr. Ekbal says that this picture has changed given that Serum Institute of India is now producing HPV vaccines at much competitive rates. While HPV vaccine manufactured by pharma majors are available in the range of ₹2,000-₹4,000/dose (there is also the HPV vaccine which protects against nine strains of HPV, costing around ₹10,850/dose), Cervavac produced by Serum Institute of India is available at ₹2,000/dose. 'HPV vaccine cost has come down and as far as dosage is concerned, there is some emerging evidence, (as per the WHO), that even a single dose delivers solid protection against HPV. That changes the picture completely. From a gender perspective, I am happy about the State's decision to protect adolescent girls against HPV,' Dr. Ekbal said. Current public health concerns However, the State should not forget its current public health concerns, which included protecting children from rabies through anti-rabies pre-exposure prophylaxis vaccine and from mumps, through an additional dose of MMR vaccine, he said. Rabies is emerging as a serious public health issue in the State, with children being a major casualty, he reminded. 'The mortality and morbidity due to influenza and pneumococcal infections is high in the elderly, the immunocompromised and those with co-morbidities. The State should prioritise annual flu vaccine and pneumococcal vaccine to protect elderly against pneumonia and meningitis,' Dr. Ekbal pointed out. He said that the Health department should recommend these vaccines so that there is more uptake for the same, which can bring down the cost of vaccines. Time to push for elimination 'Introducing HPV for adolescent girls is a policy decision that the Government had taken much earlier. Questions whether HPV vaccination is a priority now can be controversial. It is true that cervical cancer incidence is going down steadily and thus this would be the right time to push through elimination strategies. HPV vaccination is being introduced as part of the State's efforts to eliminate cervical cancer and the operational details are being worked out,' PK Jameela, member, State Planning Board, said.
Time of India
2 days ago
- Time of India
Ryne Sandberg dies after metastatic prostate cancer battle: What is it and who is at risk
Baseball legend Ryne Sandberg has passed away at 65, with his family by his side at home. Fans across the world are mourning the loss of the Hall of Fame second baseman, best known for his incredible years with the Chicago Cubs. He wasn't just a star on the field he was one of the most respected players in baseball history. Back in January 2024, Sandberg revealed he had been diagnosed with metastatic prostate cancer. He went through chemotherapy and radiation and by August, there was a moment of hope—he shared that he was cancer-free. But sadly, that didn't last. On December 10, he shared in a heartfelt Instagram post that the cancer had come back and spread to other organs. Even then, Ryne stayed positive and focused on spending meaningful time with his loved ones. What is Metastatic Prostate Cancer? It's prostate cancer that has spread beyond the prostate gland to other parts of the body. That could mean the bones, lymph nodes, liver, or even lungs. It's also called advanced or stage 4 prostate cancer. It's more serious and tougher to treat than early-stage prostate cancer. Possible symptoms include: Unexplained weight loss Pain or burning while peeing Blood in urine or semen (less common) Nausea, vomiting Worsening pain—especially in bones, if it's spread there Who's most at risk for metastatic prostate cancer? Like with most health conditions, some people are at higher risk than others when it comes to metastatic prostate cancer. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Unsold 2021 Cars Now Almost Free - Prices May Surprise You Unsold Cars | Search Ads Learn More Undo Let's break down the main risk factors you should know about. Age is a big one. Prostate cancer becomes much more common as men get older—especially after age 50. Most cases are found in men aged 65 and up, which is why doctors encourage regular checkups starting in your 50s or even earlier if you're high risk. Race and ethnicity matter, too. Black men, especially in the U.S., face a significantly higher risk of developing prostate cancer. Not only are they more likely to be diagnosed, but the disease also tends to be more aggressive and more advanced by the time it's caught. That makes early detection even more important in this group. Family history plays a big role. If your dad, brother, or son has had prostate cancer, your risk goes up. Certain inherited gene mutations—like BRCA1 and BRCA2, which you might've heard about in connection with breast cancer—can also increase your chances. Obesity is another factor. Being overweight doesn't just increase your general health risks—it can also make prostate cancer more aggressive. Obese men are also more likely to experience a recurrence of cancer after treatment. Smoking might be part of the picture, too. While it's not the biggest risk factor, some studies suggest that men who smoke may have a higher chance of developing advanced prostate cancer or having it come back after treatment. Then there are genetic conditions, like Lynch syndrome or BRCA mutations. If these run in your family, they could bump up your risk as well. Chemical exposure is one of the lesser-known risks. Men who've had high exposure to pesticides or certain industrial chemicals like cadmium may have a higher chance of developing prostate cancer, though more research is still being done. Missing regular screenings is a major problem. If you skip those routine PSA tests or doctor visits, prostate cancer may not be caught until it's already advanced. There are also some additional factors being studied—like diets super high in calcium, taller height, higher birth weight, and a lack of exercise. The evidence isn't rock solid yet, but it's worth keeping in mind.
Time of India
24-07-2025
- Time of India
Is thimerosal in vaccines a hidden danger? The debate over mercury and autism risks
Picture this: a little compound humming away inside some vaccine vials since the 1930s, quietly stopping germs from crashing the vaccine party. That's thimerosal—an organomercury compound containing around 49% mercury by weight, used as a preservative in multi-dose vaccine vials to keep bacteria and fungi at bay. When vaccine manufacturers pierce the vial multiple times, contamination risk spikes—thimerosal prevents that by killing germs before they can cause trouble. Now let's talk mercury. Unlike methylmercury—which is found in fish and can build up over time—ethylmercury (the type in thimerosal) is processed and expelled quickly by your body. Government agencies and researchers say that at the tiny doses used, it's not harmful—and the only side effects observed are minor, like redness or swelling at the jab site. Reactive allergic responses are rare but possible, and often mild—even though patch testing has identified some sensitivities in 16–18% of cases, without major clinical concern Does it heighten autism risk? Back in 1999, as fears around autism and mercury exposure swirled, the CDC, FDA, National Institutes of Health, and pediatric associations recommended removing thimerosal from childhood vaccines as a precaution—not because there was proof it was dangerous. By about 2001, most vaccines for children under six in the U.S. no longer contained it; today, vaccines like MMR, chickenpox, polio, and pneumococcal never included it at all. "There is a robust body of peer-reviewed, scientific studies conducted in the United States and countries around the world that support the safety of thimerosal-containing vaccines. The scientific evidence collected over the past 20+ years does not show any evidence of harm, including serious neurodevelopmental disorders, from use of thimerosal in vaccines. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy the Dip: Top 5 Dividend Stocks with Growth Potential Seeking Alpha Read More Undo Specifically, the Institute of Medicine (now known as the National Academy of Medicine), and others have concluded that the evidence favors rejection of a link between thimerosal and autism. Scientific studies of the risk of other serious neurodevelopmental disorders have failed to support a causal link with thimerosal," a US CDC report says. Currently, thimerosal isn't in most routine vaccines, but it still pops up in some multi-dose flu vaccine vials, especially those used in clinics or public vaccination drives where single-dose packaging isn't practical. For flu shots in the U.S., about 90–96% are thimerosal-free, but the multi-dose ones may still have up to ~25 micrograms per dose—while trace amounts might show up during manufacturing in rare vials. Recently, Robert F. Kennedy Jr.—now heading vaccine policy at HHS—appointed a new advisory panel that has started pushing to remove thimerosal entirely from flu vaccines. That move has alarmed major medical groups, warning it could reduce vaccine access in under-resourced areas and fuel fear over misunderstood risks. "Although all vaccines routinely recommended for children 6 years of age and younger in the U.S. are available in formulations that do not contain thimerosal, thimerosal has a long record of safe and effective use in preventing bacterial and fungal contamination of vaccines, with no ill effects established other than hypersensitivity and minor local reactions at the site of injection," the CDC report adds.
